Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6740162 | 7061801 | F | 6740162-4 | 20100517 | 20100525 | EXP | A0786245A | GLAXOSMITHKLINE | 64 | YR | F | Y | 20100525 | CN | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6740162 | 1013747222 | PS | AVANDIA | 1 | ORAL | 4MG PER DAY | 021071 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6740162 | 1013747222 | DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6740162 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6740162 | CEREBROVASCULAR ACCIDENT |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6740162 | 1013747222 | 20040614 | 20100507 |